Position in INSM
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$95,626,168
+$10,258,504 QoQ
Shares Held
584,798
+19.2% QoQ
Ownership
0.270%
of shares outstanding
% of Portfolio
1.63%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 75.50778217435764.ToString("F0")%
Shared 0.ToString("F0")%
None 24.49221782564236.ToString("F0")%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TimesSquare Capital Management, LLC holds $398,607,399 across 16 Biotechnology names. INSM ranks #1 (24.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
This page
|
584,798 | $95,626,168 | |
| 2 | ARGX |
Argenx SE
|
83,117 | $60,696,189 | |
| 3 | MIRM |
Mirum Pharmaceuticals, Inc.
|
376,473 | $34,778,575 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
112,342 | $29,020,185 | |
| 5 | TARS |
Tarsus Pharmaceuticals, Inc.
|
388,590 | $27,259,588 | |
| 6 | NAMS |
NewAmsterdam Pharma Co N.V.
|
751,988 | $24,071,135 | |
| 7 | XENE |
Xenon Pharmaceuticals Inc.
|
359,293 | $20,892,887 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
275,674 | $20,700,360 |
All Filings in INSM
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $95,626,168 | 584,798 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $85,367,664 | 490,506 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $61,216,490 | 425,085 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $87,908,134 | 873,491 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $81,183,850 | 1,064,148 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $47,249,871 | 684,384 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $35,322,437 | 483,869 | Shares | Sole | 2024-11-04 | |
| No filing history on record for this holder in this stock. | ||||||